LV10612A - 1-benzil-3-oksi-metilindazola vai ta salu un farmaceitiski saderigu pamatvielu iegusanas panemiens - Google Patents

1-benzil-3-oksi-metilindazola vai ta salu un farmaceitiski saderigu pamatvielu iegusanas panemiens

Info

Publication number
LV10612A
LV10612A LV930647A LV930647A LV10612A LV 10612 A LV10612 A LV 10612A LV 930647 A LV930647 A LV 930647A LV 930647 A LV930647 A LV 930647A LV 10612 A LV10612 A LV 10612A
Authority
LV
Latvia
Prior art keywords
methylindazole
islands
oxy
saturation
benzyl
Prior art date
Application number
LV930647A
Other languages
English (en)
Other versions
LV10612B (en
Inventor
Bruno Silvestrini
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of LV10612A publication Critical patent/LV10612A/lv
Publication of LV10612B publication Critical patent/LV10612B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
LVP-93-647A 1989-02-07 1993-06-22 Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier LV10612B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
LV10612A true LV10612A (lv) 1995-04-20
LV10612B LV10612B (en) 1995-08-20

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-647A LV10612B (en) 1989-02-07 1993-06-22 Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier

Country Status (36)

Country Link
US (2) US4999367A (lv)
EP (1) EP0382276B1 (lv)
JP (1) JP2870925B2 (lv)
KR (1) KR0145525B1 (lv)
CN (2) CN1046505C (lv)
AR (1) AR247386A1 (lv)
AT (1) ATE127115T1 (lv)
AU (1) AU624895B2 (lv)
BG (1) BG50273A3 (lv)
CA (1) CA2009503C (lv)
CZ (1) CZ280121B6 (lv)
DD (2) DD295363A5 (lv)
DE (2) DE382276T1 (lv)
DK (1) DK0382276T3 (lv)
EG (1) EG19170A (lv)
ES (1) ES2020171T3 (lv)
FI (1) FI102678B (lv)
GE (1) GEP19971030B (lv)
GR (2) GR910300073T1 (lv)
HU (1) HU204793B (lv)
IL (1) IL93132A (lv)
IN (1) IN170957B (lv)
IT (1) IT1230441B (lv)
LT (1) LT3604B (lv)
LV (1) LV10612B (lv)
NZ (1) NZ232258A (lv)
PE (1) PE25091A1 (lv)
PH (1) PH26552A (lv)
PL (2) PL163720B1 (lv)
PT (1) PT93067B (lv)
RO (1) RO106252B1 (lv)
RU (3) RU2066318C1 (lv)
SK (1) SK278441B6 (lv)
UA (1) UA26852C2 (lv)
YU (1) YU47943B (lv)
ZA (1) ZA90644B (lv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EP2254870B1 (en) * 2008-03-07 2016-02-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
US8461194B2 (en) 2008-03-07 2013-06-11 Aziende Chimiche Riunite Angelini Francesco A. C. R. A. F. S. P. A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
US8314099B2 (en) 2008-03-07 2012-11-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
EP2462119B1 (en) * 2009-08-03 2014-06-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required Magnesium intermediates
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
CA3095012C (en) 2012-05-01 2023-02-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2013171316A1 (en) 2012-05-18 2013-11-21 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
SI2882715T1 (sl) 2012-05-18 2017-03-31 Sanofi Derivati pirazola in njihova uporaba kot antagonisti LPAR5
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
CA3144861A1 (en) * 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
PT93067A (pt) 1990-08-31
HU204793B (en) 1992-02-28
GR910300073T1 (en) 1991-11-15
GR3018165T3 (en) 1996-02-29
ZA90644B (en) 1991-01-30
HU900689D0 (en) 1990-04-28
IN170957B (lv) 1992-06-20
EG19170A (en) 1994-11-30
EP0382276A2 (en) 1990-08-16
BG50273A3 (en) 1992-06-15
PL163720B1 (pl) 1994-04-29
JPH02240065A (ja) 1990-09-25
ATE127115T1 (de) 1995-09-15
NZ232258A (en) 1991-06-25
YU20690A (sh) 1992-07-20
CA2009503A1 (en) 1990-08-07
UA26852C2 (uk) 1999-12-29
YU47943B (sh) 1996-07-24
PL163730B1 (pl) 1994-04-29
CN1046505C (zh) 1999-11-17
IT1230441B (it) 1991-10-23
CA2009503C (en) 2000-04-11
SK56390A3 (en) 1997-05-07
CN1088201A (zh) 1994-06-22
FI900577A0 (fi) 1990-02-06
PE25091A1 (es) 1991-08-17
AR247386A1 (es) 1994-12-29
JP2870925B2 (ja) 1999-03-17
ES2020171A4 (es) 1991-08-01
HUT53088A (en) 1990-09-28
KR0145525B1 (ko) 1998-08-17
US4999367A (en) 1991-03-12
EP0382276A3 (en) 1990-12-12
IT8947620A0 (it) 1989-02-07
DE382276T1 (de) 1991-11-28
DK0382276T3 (da) 1996-01-15
SK278441B6 (en) 1997-05-07
IL93132A0 (en) 1990-11-05
AU4906690A (en) 1990-08-16
DE69021902D1 (de) 1995-10-05
DD291995A5 (de) 1991-07-18
RU2044729C1 (ru) 1995-09-27
EP0382276B1 (en) 1995-08-30
RO106252B1 (ro) 1993-03-31
LT3604B (en) 1995-12-27
CZ280121B6 (cs) 1995-11-15
CN1034016C (zh) 1997-02-12
RU2055071C1 (ru) 1996-02-27
PT93067B (pt) 1995-12-29
ES2020171T3 (es) 1995-12-01
LTIP872A (en) 1995-03-27
DD295363A5 (de) 1991-10-31
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
KR900012913A (ko) 1990-09-03
PH26552A (en) 1992-08-19
FI102678B (fi) 1999-01-29
AU624895B2 (en) 1992-06-25
LV10612B (en) 1995-08-20
CZ56390A3 (en) 1995-06-14
DE69021902T2 (de) 1996-05-23
US5112986A (en) 1992-05-12
RU2066318C1 (ru) 1996-09-10
IL93132A (en) 1994-05-30
CN1044810A (zh) 1990-08-22

Similar Documents

Publication Publication Date Title
LV10612A (lv) 1-benzil-3-oksi-metilindazola vai ta salu un farmaceitiski saderigu pamatvielu iegusanas panemiens
DE69233474D1 (de) Pharmazeutische Zusammensetzung enthaltend S-Nitrosoimmunoglobuline und Verwendung davon
BR1100824A (pt) Composto e composição farmacêutica
NO920109L (no) Biologisk nedbrytbar toeymykningsblanding eller -gjenstandog fremstilling derav
MX9205721A (es) Metodo de uso y composiciones de win 49596-finasteride
BR9002566A (pt) Copolimero enxertado de etileno-alfa-olefina e composicao oleaginosa
EP0421436A3 (en) Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity
FI96327B (fi) Ferriittis-perliittisen teräksen käyttö
GB8919726D0 (en) Ws7338 substances and preparation thereof
BR8902476A (pt) Estrutura absorvente e produto absorvente
EP0532757A4 (en) Highly sensitive assay of tissue factor and kit therefor
BR8903389A (pt) Conjunto moto-redutor e utilizacao do mesmo
ZA902345B (en) Substituted dibenzofurans and methods of using same
ITVI910031A1 (it) Struttura reticolare componibile e modulare
KR910001193U (ko) 와 전류계
BR8905729A (pt) Composicao e emprego
FI945493A (fi) Ti (III)-pitoisen liuoksen valmistus ja sen käyttö
GB8901996D0 (en) Compounds and use
ATA163289A (de) Sicht- und/oder stuetzwand
LV5528A3 (lv) L-alanil-l-prolina atvasinajumu vai to farmaceitiski derigu salu iegusanas panemiens
BR8903829A (pt) Purificacao de telomeros preparados de cloro-tri-fluor-etileno e tri-cloro-tri-fluor-etano
BR8906072A (pt) Estrutura expositora de quadros e informativos
HU9300271V0 (en) Space dividing and/or holding structure built up of elements
HU910635D0 (en) Space dividing and/or holding structure built up of elements
KR940009313U (ko) 소독겸용 불고기판과 수저통